XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2
FAIR VALUE MEASUREMENTS (Tables)
 3 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of Recurring Fair Value Measurements The financial instruments measured at fair value in the accompanying condensed consolidated balance sheets consist of the following:
Recurring Fair Value Measurements
as of June 30, 2022
Level 1Level 2Level 3Total
Assets:
Current derivative instruments (2)
$— $3,424 $— $3,424 
Long-term deferred compensation plan asset (1)
20,186 — — 20,186 
Long term derivative instruments (2)
— 4,099 — 4,099 
Total Assets$20,186 $7,523 $— $27,709 
Liabilities:
Long-term deferred compensation plan liability (1)
20,186 — — 20,186 
Total Liabilities$20,186 $— $— $20,186 
Recurring Fair Value Measurements
as of March 31, 2022
Level 1Level 2Level 3Total
Assets:
Long-term deferred compensation plan asset (1)
$16,512 $— $— $16,512 
Long term derivative instruments (2)
— 4,088 — 4,088 
Total Assets$16,512 $4,088 $— $20,600 
Liabilities:
Current derivative instruments (2)
$— $4,324 $— $4,324 
Long-term derivative instruments (2)
— 39 — 39 
Long-term deferred compensation plan liability (1)
16,512 — — 16,512 
Total Liabilities$16,512 $4,363 $— $20,875 
(1) Investments in this category consist primarily of mutual funds whose fair values are determined by reference to the quoted market price per unit in active markets multiplied by the number of units held without consideration of transaction costs. These assets and liabilities represent investments held in a consolidated trust to fund the Company's non-qualified deferred compensation plan and are recorded in other long-term assets and other long-term liabilities on our condensed consolidated balance sheets.
(2) The Company’s interest rate swaps are considered over-the-counter derivatives and fair value is estimated based on the present value of future cash flows using a model-derived valuation that uses Level 2 observable inputs such as interest rate yield curves. See Note 9 to the condensed consolidated financial statements for further discussion on the Company’s derivative instruments designated as cash flow hedges.